BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31408432)

  • 1. LncRNA MALAT1 inhibits hypoxia/reoxygenation-induced human umbilical vein endothelial cell injury via targeting the microRNA-320a/RAC1 axis.
    Zhu R; Hu X; Xu W; Wu Z; Zhu Y; Ren Y; Cheng L
    Biol Chem; 2020 Feb; 401(3):349-360. PubMed ID: 31408432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
    Liu Z; Guo N; Zhang XJ
    Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lncRNA MALAT1 participates in regulating coronary slow flow endothelial dysfunction through the miR-181b-5p-MEF2A-ET-1 axis.
    Zhao C; Zong Z; Zhu Q; Wang Y; Li X; Zhang C; Ma C; Xue Y
    Vascul Pharmacol; 2021 Jun; 138():106841. PubMed ID: 33545365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA MALAT1 affects intermittent hypoxia-induced endothelial injury by regulating miR-142-3p/HMGB1.
    Chen MX; Chen LD; Huang JC; Zeng AM; Huang JF; Lin QC
    Sleep Breath; 2022 Dec; 26(4):2015-2024. PubMed ID: 35006556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MALAT1 aggravates the retinal angiogenesis via miR-320a/HIF-1α axis in diabetic retinopathy.
    Chen Z; Yang J; Gao Y; Jiang S; Li Z; Wang Y; Hu Z; Han F; Ni N
    Exp Eye Res; 2022 May; 218():108984. PubMed ID: 35202706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis.
    Zhang C; Yang H; Li Y; Huo P; Ma P
    Mol Cell Biochem; 2020 Apr; 467(1-2):15-25. PubMed ID: 32072428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of MALAT1 expression inhibits HUVEC proliferation by upregulation of miR-320a and downregulation of FOXM1 expression.
    Sun JY; Zhao ZW; Li WM; Yang G; Jing PY; Li P; Dang HZ; Chen Z; Zhou YA; Li XF
    Oncotarget; 2017 Sep; 8(37):61499-61509. PubMed ID: 28977880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis.
    Luo L; Wang Y; Hu P; Wu J
    Med Sci Monit; 2020 Mar; 26():e920478. PubMed ID: 32222724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MALAT1 Promotes STAT3-Mediated Endothelial Inflammation by Counteracting the Function of miR-590.
    Zhou Q; Run Q; Li CY; Xiong XY; Wu XL
    Cytogenet Genome Res; 2020; 160(10):565-578. PubMed ID: 33022677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALAT1 affects hypoxia-induced vascular endothelial cell injury and autophagy by regulating miR-19b-3p/HIF-1α axis.
    Liu H; Shi C; Deng Y
    Mol Cell Biochem; 2020 Mar; 466(1-2):25-34. PubMed ID: 31933110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-150 affects endoplasmic reticulum stress via MALAT1-miR-150 axis-mediated NF-κB pathway in LPS-challenged HUVECs and septic mice.
    Liu L; Yan LN; Sui Z
    Life Sci; 2021 Jan; 265():118744. PubMed ID: 33181172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA Malat1 is a potent autophagy inducer protecting brain microvascular endothelial cells against oxygen-glucose deprivation/reoxygenation-induced injury by sponging miR-26b and upregulating ULK2 expression.
    Li Z; Li J; Tang N
    Neuroscience; 2017 Jun; 354():1-10. PubMed ID: 28433650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MALAT1 up-regulates VEGF-A and ANGPT2 to promote angiogenesis in brain microvascular endothelial cells against oxygen-glucose deprivation via targetting
    Ren L; Wei C; Li K; Lu Z
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30038058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA TTTY15 regulates hypoxia-induced vascular endothelial cell injury via targeting miR-186-5p in cardiovascular disease.
    Zheng J; Zhuo YY; Zhang C; Tang GY; Gu XY; Wang F
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3293-3301. PubMed ID: 32271447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis.
    Wu Q; Wang J; Tan WLW; Jiang Y; Wang S; Li Q; Yu X; Tan J; Liu S; Zhang P; Tiang Z; Chen Z; Foo RS; Yang HT
    Cell Death Dis; 2020 May; 11(5):354. PubMed ID: 32393784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long noncoding RNA PDK1-AS/miR-125b-5p/VEGFA axis modulates human dermal microvascular endothelial cell and human umbilical vein endothelial cell angiogenesis after thermal injury.
    Zhou S; Liang P; Zhang P; Zhang M; Huang X
    J Cell Physiol; 2021 Apr; 236(4):3129-3142. PubMed ID: 33078418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MIAT Mediates ox-LDL-Induced Endothelial Cell Injury Via miR-206/RAB22A Axis.
    Gao Y; Yue J; Huang Z
    J Surg Res; 2021 Sep; 265():303-312. PubMed ID: 33965771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA FTX alleviates hypoxia/reoxygenation-induced cardiomyocyte injury via miR-410-3p/Fmr1 axis.
    Li L; Li L; Zhang YZ; Yang HY; Wang YY
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):396-408. PubMed ID: 31957854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MALAT1 affects high glucose-induced endothelial cell proliferation, apoptosis, migration and angiogenesis by regulating the PI3K/Akt signaling pathway.
    Zhang SH; Zhang SG; Zhou P; Wei X; Mao XD; Lin SG; Liu C
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8551-8559. PubMed ID: 31646587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ox-LDL-induced lncRNA MALAT1 promotes autophagy in human umbilical vein endothelial cells by sponging miR-216a-5p and regulating Beclin-1 expression.
    Wang K; Yang C; Shi J; Gao T
    Eur J Pharmacol; 2019 Sep; 858():172338. PubMed ID: 31029709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.